Trial intelligence / Profile preview

Comparison of intravenous plus intra-articular vs intra-articular tranexamic acid in total knee arthroplasty

IRCT20220222054093N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in postoperative hemorrhage (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Postoperative bleeding volume. Started Oct 2022; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on IRCT20220222054093N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220222054093N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call